Katalin Korpany is a Scientist II at Adaptive Biotechnologies Corp., specializing in DNA and RNA nanopore sequencing since August 2022. Prior to this role, Katalin held positions as a Research Scientist/Engineer at the University of Washington, where significant contributions included implementing sequencing workflows and bioinformatics analysis pipelines. Katalin also served as Adjunct/Adjoint Faculty and Postdoctoral Research Associate at Washington State University, developing computational methods for data analysis and investigating self-assembled porphyrins via scanning tunneling microscopy. With a strong foundation in programming and data visualization, Katalin has published extensively, including two first-author peer-reviewed manuscripts, and has experience mentoring undergraduate students. Educational qualifications include a PhD in Chemistry from McGill University and a Certificate in Software Development & Design Essentials from UW Professional & Continuing Education.
Adaptive Biotechnologies
14 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.